Robeco Institutional Asset Management B.V. lessened its holdings in shares of DocuSign, Inc. (NASDAQ:DOCU - Free Report) by 40.8% during the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 768,177 shares of the company's stock after selling 528,340 shares during the period. Robeco Institutional Asset Management B.V. owned 0.38% of DocuSign worth $69,090,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors also recently made changes to their positions in DOCU. Dimensional Fund Advisors LP increased its position in DocuSign by 14.0% in the 2nd quarter. Dimensional Fund Advisors LP now owns 610,728 shares of the company's stock valued at $32,671,000 after acquiring an additional 75,133 shares in the last quarter. Sei Investments Co. lifted its position in DocuSign by 16.4% during the 2nd quarter. Sei Investments Co. now owns 22,341 shares of the company's stock valued at $1,195,000 after purchasing an additional 3,141 shares during the period. MBB Public Markets I LLC acquired a new position in DocuSign during the 2nd quarter valued at about $781,000. The Manufacturers Life Insurance Company boosted its stake in shares of DocuSign by 3.2% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 52,260 shares of the company's stock valued at $2,796,000 after purchasing an additional 1,628 shares during the last quarter. Finally, Mackenzie Financial Corp grew its position in shares of DocuSign by 25.4% during the 2nd quarter. Mackenzie Financial Corp now owns 68,833 shares of the company's stock worth $3,683,000 after buying an additional 13,944 shares during the period. 77.64% of the stock is currently owned by institutional investors and hedge funds.
Insider Transactions at DocuSign
In other news, CEO Allan C. Thygesen sold 7,763 shares of the business's stock in a transaction that occurred on Monday, December 2nd. The stock was sold at an average price of $80.54, for a total transaction of $625,232.02. Following the transaction, the chief executive officer now directly owns 100,062 shares of the company's stock, valued at approximately $8,058,993.48. The trade was a 7.20 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Peter Solvik sold 10,000 shares of the company's stock in a transaction that occurred on Friday, January 10th. The stock was sold at an average price of $91.26, for a total value of $912,600.00. Following the transaction, the director now owns 150,253 shares in the company, valued at $13,712,088.78. This trade represents a 6.24 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 693,537 shares of company stock worth $66,575,817 in the last quarter. 1.66% of the stock is currently owned by corporate insiders.
Analyst Upgrades and Downgrades
A number of equities analysts have issued reports on DOCU shares. Royal Bank of Canada reaffirmed a "sector perform" rating and issued a $90.00 price objective (up from $57.00) on shares of DocuSign in a research note on Friday, December 6th. Citigroup raised their price target on DocuSign from $87.00 to $113.00 and gave the stock a "buy" rating in a research report on Friday, December 6th. Morgan Stanley increased their price target on DocuSign from $62.00 to $97.00 and gave the stock an "equal weight" rating in a report on Friday, December 6th. Hsbc Global Res upgraded DocuSign to a "moderate sell" rating in a report on Friday, December 6th. Finally, JMP Securities reissued a "market outperform" rating and issued a $124.00 target price on shares of DocuSign in a research note on Tuesday, January 7th. Three research analysts have rated the stock with a sell rating, seven have given a hold rating and three have issued a buy rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of "Hold" and an average target price of $92.45.
Check Out Our Latest Analysis on DocuSign
DocuSign Trading Up 0.4 %
NASDAQ DOCU traded up $0.39 during trading hours on Thursday, hitting $95.85. The company's stock had a trading volume of 1,521,512 shares, compared to its average volume of 2,088,573. The company has a market capitalization of $19.36 billion, a PE ratio of 19.76, a price-to-earnings-growth ratio of 8.30 and a beta of 0.88. DocuSign, Inc. has a 52 week low of $48.70 and a 52 week high of $107.86. The company's 50-day simple moving average is $90.73 and its two-hundred day simple moving average is $72.41.
About DocuSign
(
Free Report)
DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.
Recommended Stories
Before you consider DocuSign, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DocuSign wasn't on the list.
While DocuSign currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for February 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.